ORIFARM GROUP A/S: Financial statements 2020
CVR: 27347282
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ORIFARM GROUP A/S (CVR 27347282) has filed annual accounts for 2020. In 2020, the company reported revenue of EUR 8,627,000 and a net result of EUR 25,518,000 compared with EUR 34,737,000 the year before. That is a decrease of 37.8% compared with the year before. The profit margin was 295.8%. Equity in the 2020 report amounted to EUR 148,963,000. The solvency ratio was 42.2%. The company had 1,177 employees in the financial year.
- Revenue
- EUR 8,627,000
- Gross Profit
- EUR 8,664,000
- Profit/Loss
- EUR 25,518,000
- Equity
- EUR 148,963,000
- Total Assets
- EUR 353,106,000
- Employees
- 1,177
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 8.6M EUR | 8.7M EUR | 25.5M EUR | 149M EUR | 1177 |
| 2019 | 13.9M EUR | 13.9M EUR | 34.7M EUR | 167.9M EUR | 1111 |
| 2018 | 10M EUR | 10.1M EUR | 26.5M EUR | 136M EUR | 1036 |
| 2017 | 8.6M EUR | 8.8M EUR | 21.9M EUR | 117M EUR | 797 |
| 2016 | 8.8M EUR | 8.8M EUR | 10.2M EUR | 98.5M EUR | 960 |
Official annual report
How creditworthy is ORIFARM GROUP A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of August 21, 2020, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of August 21, 2020, Niels Harald de Coninck-Smith has left the board of directors of ORIFARM GROUP A/S.
As of August 20, 2020, Hans Carl Bøgh-Sørensen has left the board of directors of ORIFARM GROUP A/S.
As of August 13, 2020, Anders Hagh has joined the board of directors of ORIFARM GROUP A/S.
As of June 29, 2020, Lars Monrad-Gylling has left the board of directors of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2019. Revenue came to DKK 13,878,000, and the net result was DKK 34,737,000.
As of March 16, 2020, Søren Møller Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Jens Christian Greve has joined the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Mette Bille Rasmussen has joined the board of directors of ORIFARM GROUP A/S.
As of March 16, 2020, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
About ORIFARM GROUP A/S
ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 211 employees (2026). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.